BioSpace News Archive

Cerillo, a biotechnology company at the forefront of developing advanced research platforms for the study of the microbiome, will host demonstrations of the company’s new co-culture duet system at ASM Microbe 2023 from June 16-18th in Houston, Texas at booth #704.

Encinitas, California--(Newsfile Corp. - June 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced its President & CEO, Brian Strem, Ph.D., will participate in two upcoming investor conferences

Invirsa Inc., a privately held, clinical-stage pharmaceutical company focused on developing an innovative topically administered eyedrop formulation INV-102 for ocular conditions associated with DNA damage, announced the closing of a $7.7 million Series B financing completed in April earlier this year.

Indivior PLC announced the acceptance of four abstracts for presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug Dependence taking place June 17-21, 2023, in Denver, Colorado.

Ravensburg, June 14, 2023: Vetter, one of the world’s leading Contract Development and Manufacturing Organizations (CDMO), is consistently pursuing improvements to its sustainability strategy.

Ipsen announced that the U.S. Food and Drug Administration has accepted its supplemental new drug application Onivyde® plus 5 fluorouracil/leucovorin and oxaliplatin as a potential first-line treatment for metastatic pancreatic ductal adenocarcinoma.

Aldeyra Therapeutics, Inc. announced it will host a webcast and conference call on Thursday, June 15, 2023, at 8:00 a.m. to provide top-line results from the Phase 3 INVIGORATE‑2 Trial of reproxalap in allergic conjunctivitis.

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces that management will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on Tuesday, June 20 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time).

Amsterdam, the Netherlands – Royal Philips announced that it will repurchase up to 7.1 million shares to cover certain of its obligations arising from its long-term incentive plans.

Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced that Joseph G. Cremonese, a member of the Company’s board of directors is retiring and has therefore, resigned, from the Company’s Board of Directors, effective June 13, 2023.